Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis

BACKGROUND: Due to the presence of both classical estrogen receptor (ERα) and another ER subtype (ERβ) in ovarian cancer, hormonal treatment is an attractive option. However, response to tamoxifen in ovarian cancer is modest. The presence of ERβ variants further complicated the issue. We have recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Karen K. L., Siu, Michelle K. Y., Jiang, Yu-xin, Wang, Jing-jing, Wang, Yan, Leung, Thomas H. Y., Liu, Stephanie S., Cheung, Annie N. Y., Ngan, Hextan Y. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579953/
https://www.ncbi.nlm.nih.gov/pubmed/28859612
http://dx.doi.org/10.1186/s12885-017-3601-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579953/
https://www.ncbi.nlm.nih.gov/pubmed/28859612
http://dx.doi.org/10.1186/s12885-017-3601-1

Ejemplares similares